Concepedia
Statistics
Publications
14
Citations
864
H-Index
13
Active since
2009
Affiliations
BioPhage Pharma (Canada)(Current)
Esteve (Spain)
Altasciences (Canada)
University of Alberta
Royal Perth Hospital
Éric Sicard is an author at BioPhage Pharma (Canada) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.
Publications per year
2009–2022
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
Kosh Agarwal, Scott Fung, Tuan Nguyen et al. · Journal of Hepatology · 2014 · 197 citations
Medicine, Pharmacokinetics, Pharmacology +12
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Edward Gane, Young‐Suk Lim, Stuart C. Gordon et al. · Journal of Hepatology · 2015 · 185 citations
Medicine, Immunology, Pharmacology +11
Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers
Martin Bitzan, Ruth Poole, Mariam Mehran et al. · Antimicrobial Agents and Chemotherapy · 2009 · 95 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study
Stephen A. Harrison, Federico Pérez Manghi, William B. Smith et al. · Nature Medicine · 2022 · 72 citations · Full text
Medicine, Internal Medicine, Pharmacology +8
The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies
John F. Kokai‐Kun, Tracey Roberts, Olivia Coughlin et al. · Antimicrobial Agents and Chemotherapy · 2017 · 65 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +11
1–5 of 14